Rules-Driven Sales Factory for Life Sciences
Raycaster
This turns life sciences business development from manual list building into a rules driven sales factory. Instead of waiting for a rep to notice that a CDMO raised money or got an FDA warning letter, Raycaster watches those signals, decides whether the account matches the customer’s ideal pipeline, finds the likely operations, quality, and technical buyers, then prepares the first outbound touch and hands off to scheduling when someone engages.
-
The important product choice is that Raycaster is not just a database or just an email tool. It sits between signal detection and workflow execution, similar to how Apollo and ZoomInfo combine buying signals, contact discovery, and engagement sequences, but Raycaster tailors that motion to life sciences events like IND filings, facility changes, and sponsor vendor onboarding.
-
In practice, identifying the buying committee matters more in biotech than in standard SaaS. A provider sale can involve tech ops, CMC, QA, regulatory, and procurement, and Raycaster’s own research describes drug development as a multi party coordination problem across sponsors, CDMOs, CROs, labs, and regulators. That makes account level orchestration more valuable than single contact prospecting.
-
Booking the demo is the last mile. Once outreach and reply handling are automated, the product starts to look less like research software and more like an always on SDR for niche life sciences vendors. That can raise revenue per customer because the same signal engine that helps with document work can also support commercial teams chasing new accounts.
The next step is deeper automation around account level playbooks. As more life sciences vendors want software that watches the market, finds the right stakeholders, and moves qualified accounts straight into meetings, the winning products will be the ones that connect industry specific signals to real sales actions, not just better search.